Skip to main content

Growing Antibiotic Resistance in Fatal Cases of Staphylococcal Pneumonia in the Elderly

  • Chapter
  • First Online:
Respiratory Contagion

Part of the book series: Advances in Experimental Medicine and Biology ((NR,volume 905))

Abstract

Older people are often especially susceptible to pneumonia and bacteria may develop resistance to antibiotics quicker in the elderly, whose immune systems gradually diminish. This study analyses, retrospectively, resistance to antibiotics in high-risk elderly patients with fatal pneumonia. Records of all patients aged over 65 who did not survive a bout with pneumonia were gathered from the records of the Department of Pneumology of HELIOS Clinic in Wuppertal, Germany from the period of 2004–2014. Susceptibility testing was executed for the study population, whose pneumonia was triggered by various kinds of bacteria. We detected 936 pneumonia patients of the overall mean age of 68.0 ± 13.6 years, with the following pneumonia types: 461 (49.3 %) community-acquired, 354 (37.8 %) nosocomial-acquired, and 121 (12.9 %) aspiration pneumonia. There were 631 (67.4 %) males and 305 (32.6 %) females there. We identified 672 (71.8 %) patients who had a high risk for pneumonia, especially staphylococcal pneumonia (p < 0.0001). The elderly patients had a higher risk of dying from pneumonia (2.9 odds ratio, 95 % confidence interval 1.8–4.6; p < 0.0001); of the 185 pneumonia-related deaths, 163 (88.1 %) were in the elderly. In those with fatal staphylococcal pneumonia, a high antibiotic resistance rate was found for piperacillin-tazobactam (p = 0.044), cefuroxime (p = 0.026), cefazolin (p = 0.043), levofloxacin (p = 0.018), erythromycin (p = 0.004), and clindamycin (p = 0.025). We conclude that elderly patients with staphylococcal pneumonia show resistance to common antibiotics. However, no significant antibiotic resistance could be ascribed for other types of pneumonia in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Barlett JG (1987) Diagnosis of bacterial infections of the lung. Clin Chest Med 8:119–134

    Google Scholar 

  • Bauer AW, Kirby WM, Sherris JC, Turck M (1996) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493–496

    Google Scholar 

  • Chong CP, Street PR (2008) Pneumonia in the elderly: a review of severity assessment, prognosis, mortality, prevention, and treatment. South Med J 101(11):1134–1140

    Article  PubMed  Google Scholar 

  • CLSI (2012) Clinical and Laboratory Standards Institute (2012) Performance standards for antimicrobial susceptibility testing. CLSI M100-S22. http://clsi.org/blog/2012/01/13/clsi-publishes-2012-antimicrobial-susceptibility-testing-standards/. Accessed 14 July 2015

  • Colakoğlu S, Alişkan H, Turunç T, Demiroğlu YZ, Arslan H (2008) Prevalence of inducible clindamycin resistance in Staphylococcus aureus strains isolated from clinical samples. Mikrobiyol Bul 42(3):407–412 (Article in Turkish)

    Google Scholar 

  • Cunha BA (2001) Pneumonia in the elderly. Clin Microbiol Infect 7(11):581–588

    Article  CAS  PubMed  Google Scholar 

  • Dikensoy O, Usalan C, Filiz A (2002) Foreign body aspiration: clinical utility of flexible bronchoscopy. Postgrad Med J 78(921):399–403

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Donowitz GR, Cox HL (2007) Bacterial community-acquired pneumonia in older patients. Clin Geriatr Med 23(3):515–534

    Article  PubMed  Google Scholar 

  • El-Solh AA, Sikka P, Ramadan F, Davies J (2001) Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 163(3 Pt 1):645–651

    Article  CAS  PubMed  Google Scholar 

  • EUCAST (2011) European Committee on antimicrobial susceptibility testing breakpoints 2011–2014. http://www.eucast.org. Accessed 14 July 2015

  • Feikin DR, Schuchat A, Kolczak M et al (2000) Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997. Am J Public Health 90(2):223–229

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Feldman C (2001) Pneumonia in the elderly. Med Clin North Am 85(6):1441–1459

    Article  CAS  PubMed  Google Scholar 

  • Gin A, Dilay L, Karlowsky JA, Walkty A, Rubinstein E, Zhanel GG (2007) Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination. Expert Rev Anti Infect Ther 5(3):365–383

    Article  CAS  PubMed  Google Scholar 

  • Guay D (2007) Update on clindamycin in the management of bacterial, fungal and protozoal infections. Expert Opin Pharmacother 8(14):2401–2444

    Article  CAS  PubMed  Google Scholar 

  • Gutiérrez F, Masiá M, Mirete C, Soldán B, Rodríguez JC, Padilla S, Hernández I, Royo G, Martin-Hidalgo A (2006) The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect 53(3):166–174

    Google Scholar 

  • Hashemi SH, Soozanchi G, Jamal-Omidi S, Yousefi-Mashouf R, Mamani M, Seif-Rabiei MA (2010) Bacterial aetiology and antimicrobial resistance of community-acquired pneumonia in the elderly and younger adults. Trop Doct 40(2):89–91

    Article  PubMed  Google Scholar 

  • Hidalgo M, Reyes J, Cárdenas AM, Díaz L, Rincón S, Vanegas N, Díaz PL, Castañeda E, Arias CA (2008) Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci. Biomedica 28(2):284–294 (Article in Spanish)

    Google Scholar 

  • Jalil A, Niazi ID, Khan SU (2008) Evaluation of restoration of sensitivities of resistant Staphylococcus aureus isolates by using cefuroxime and clavulanic acid in combination. J Ayub Med Coll Abbottabad 20(2):28–30

    PubMed  Google Scholar 

  • Kader AA, Kumar A, Krishna A (2005) Induction of clindamycin resistance in erythromycin-resistant, clindamycin susceptible and methicillin-resistant clinical Staphylococcal isolates. Saudi Med J 26(12):1914–1917

    PubMed  Google Scholar 

  • Kim HB, Lee B, Jang HC, Kim SH, Kang CI, Choi YJ, Park SW, Kim BS, Kim EC, Oh MD, Choe KW (2004) A high frequency of macrolide-lincosamide-streptogramin resistance determinants in Staphylococcus aureus isolated in South Korea. Microb Drug Resist 10(3):248–254

    Article  CAS  PubMed  Google Scholar 

  • Marik PE (2001) Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 344(9):665–671

    Article  CAS  PubMed  Google Scholar 

  • Marrie TJ (2000) Community-acquired pneumonia in the elderly. Clin Infect Dis 31(4):1066–1078

    Article  CAS  PubMed  Google Scholar 

  • Millett ER, Quint JK, Smeeth L, Daniel RM, Thomas SL (2013) Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study. PLoS One 8(9), e75131

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mukae H, Kawanami T, Yatera K, Yanagihara K, Yamamoto Y, Kakeya H, Tokimatsu I, Kadota J, Kohno S (2014) Efficacy and safety of levofloxacin in patients with bacterial pneumonia evaluated according to the new “Clinical evaluation methods for new antimicrobial agents to treat respiratory infections (Second Version)”. J Infect Chemother 20(7):417–422

    Article  CAS  PubMed  Google Scholar 

  • Nasiri MI, Naqvi SB, Zaidi AA, Saeed R, Raza G (2013) Comparative study on resistant pattern of clinical isolates against levofloxacin and cefepime. Pak J Pharm Sci 26(2):415–419

    CAS  PubMed  Google Scholar 

  • Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N et al (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754

    Article  CAS  PubMed  Google Scholar 

  • Pachon J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A (1990) Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis 142(2):369–373

    Article  CAS  PubMed  Google Scholar 

  • Pepersack T (2014) Specificities of pneumonia in geriatrics. Rev Med Brux 35(4):368–374 (Article in French)

    Google Scholar 

  • Petrosillo N, Cataldo MA, Pea F (2015) Treatment options for community-acquired pneumonia in the elderly people. Expert Rev Anti Infect Ther 13(4):473–485

    CAS  PubMed  Google Scholar 

  • Piątkowska E, Piątkowski J, Przondo-Mordarska A (2012) The strongest resistance of Staphylococcus aureus to erythromycin is caused by decreasing uptake of the antibiotic into the cells. Cell Mol Biol Lett 17(4):633–645

    PubMed  Google Scholar 

  • Prabhu K, Rao S, Rao V (2011) Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. J Lab Phys 3(1):25–27

    CAS  Google Scholar 

  • Riquelme OR, Riquelme OM, Rioseco ZML, Gómez MV, Cárdenas G, Torres C (2008) Community-acquired pneumonia in the elderly: clinical and nutritional aspects. Rev Med Chil 136(5):587–593 (Article in Spanish)

    Google Scholar 

  • Schito GC (2006) The importance of the development of antibiotic resistance in Staphylococcus aureus. Clin Microbiol Infect 12(Suppl 1):3–8

    Article  CAS  PubMed  Google Scholar 

  • Shoji T, Hirai Y, Osawa M, Totsuka K (2014) Cefazolin therapy for methicillin-susceptible Staphylococcus aureus bacteremia in Japan. J Infect Chemother 20(3):175–180

    Article  CAS  PubMed  Google Scholar 

  • Skov R, Frimodt-Møller N, Espersen F (2002) In vitro susceptibility of Staphylococcus aureus towards amoxycillin-clavulanic acid, penicillin-clavulanic acid, dicloxacillin and cefuroxime. APMIS 110(7–8):559–564

    Article  CAS  PubMed  Google Scholar 

  • Watkins RR, Lemonovich TL (2011) Diagnosis and management of community-acquired pneumonia in adults. Am Fam Physician 83:1299–1306

    PubMed  Google Scholar 

  • WHO (2015) International Classification of Diseases (ICD). http://www.who.int/classification/icd/en/. Accessed 6 June 2015

  • Yilmaz G, Aydin K, Iskender S, Caylan R, Koksal I (2007) Detection and prevalence of inducible clindamycin resistance in staphylococci. J Med Microbiol 56(Pt 3):342–345

    Article  PubMed  Google Scholar 

  • Ying L, Tang D (2010) Recent advances in the medicinal chemistry of novel erythromycin-derivatized antibiotics. Curr Top Med Chem 10(14):1441–1449

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of Interests

The authors declare no competing financial or otherwise interests in relation to this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Josef Yayan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Yayan, J., Rasche, K. (2015). Growing Antibiotic Resistance in Fatal Cases of Staphylococcal Pneumonia in the Elderly. In: Pokorski, M. (eds) Respiratory Contagion. Advances in Experimental Medicine and Biology(), vol 905. Springer, Cham. https://doi.org/10.1007/5584_2015_184

Download citation

Publish with us

Policies and ethics